Intellia Therapeutics Head office building

SEC Filing
Details

Document Details

Form
Filing Date
Sep 4, 2015
Document Date
Sep 4, 2015
Form Description
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Filing Group
Registration Statements
Company
Intellia Therapeutics
Issuer
Intellia Therapeutics, Inc.